Evodiamine sensitizes U87 glioblastoma cells to TRAIL via the death receptor pathway

Muhammad Noman Khan(Dalian Medical University), Hongwen Gao(Jilin University)
Molecular Medicine Reports
October 20, 2014
Cited by 39


Related Papers